BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36152319)

  • 1. Prognostic value of an APOBEC3 deletion polymorphism for glioma patients in Taiwan.
    Chen CH; Wei KC; Liao WC; Lin YY; Chen HC; Feng LY; Liu CH; Huang CY; Chen KT; Wu CS; Chang YS; Yu JS; Chang IY
    J Neurosurg; 2023 May; 138(5):1325-1337. PubMed ID: 36152319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism.
    Chen TW; Lee CC; Liu H; Wu CS; Pickering CR; Huang PJ; Wang J; Chang IY; Yeh YM; Chen CD; Li HP; Luo JD; Tan BC; Chan TEH; Hsueh C; Chu LJ; Chen YT; Zhang B; Yang CY; Wu CC; Hsu CW; See LC; Tang P; Yu JS; Liao WC; Chiang WF; Rodriguez H; Myers JN; Chang KP; Chang YS
    Nat Commun; 2017 Sep; 8(1):465. PubMed ID: 28878238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study population.
    Göhler S; Da Silva Filho MI; Johansson R; Enquist-Olsson K; Henriksson R; Hemminki K; Lenner P; Försti A
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):273-6. PubMed ID: 26320772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population.
    Ezzikouri S; Kitab B; Rebbani K; Marchio A; Wain-Hobson S; Dejean A; Vartanian JP; Pineau P; Benjelloun S
    J Viral Hepat; 2013 Oct; 20(10):678-86. PubMed ID: 24010642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer.
    Liu J; Sieuwerts AM; Look MP; van der Vlugt-Daane M; Meijer-van Gelder ME; Foekens JA; Hollestelle A; Martens JW
    PLoS One; 2016; 11(8):e0161731. PubMed ID: 27552096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Polymorphisms Predisposing the Interleukin 6-Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations.
    Liu W; Wu J; Yang F; Ma L; Ni C; Hou X; Wang L; Xu A; Song J; Deng Y; Xian L; Li Z; Wang S; Chen X; Yin J; Han X; Li C; Zhao J; Cao G
    Clin Cancer Res; 2019 Sep; 25(18):5525-5536. PubMed ID: 31152021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation.
    Wen WX; Soo JS; Kwan PY; Hong E; Khang TF; Mariapun S; Lee CS; Hasan SN; Rajadurai P; Yip CH; Mohd Taib NA; Teo SH
    Breast Cancer Res; 2016 May; 18(1):56. PubMed ID: 27233495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
    Wang J; Shaban NM; Land AM; Brown WL; Harris RS
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of calcification and contrast enhancement pattern for molecular diagnosis and survival prediction of gliomas based on the 2016 World Health Organization Classification.
    Michiwaki Y; Hata N; Mizoguchi M; Hiwatashi A; Kuga D; Hatae R; Akagi Y; Amemiya T; Fujioka Y; Togao O; Suzuki SO; Yoshimoto K; Iwaki T; Iihara K
    Clin Neurol Neurosurg; 2019 Dec; 187():105556. PubMed ID: 31639630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors.
    Middlebrooks CD; Banday AR; Matsuda K; Udquim KI; Onabajo OO; Paquin A; Figueroa JD; Zhu B; Koutros S; Kubo M; Shuin T; Freedman ND; Kogevinas M; Malats N; Chanock SJ; Garcia-Closas M; Silverman DT; Rothman N; Prokunina-Olsson L
    Nat Genet; 2016 Nov; 48(11):1330-1338. PubMed ID: 27643540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection of Bronchial Epithelial Cells by the Human Adenoviruses A12, B3, and C2 Differently Regulates the Innate Antiviral Effector APOBEC3B.
    Lejeune N; Poulain F; Willemart K; Blockx Z; Mathieu S; Gillet NA
    J Virol; 2021 Jun; 95(13):e0241320. PubMed ID: 33853956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penis.
    Trimmel B; Oszwald A; Diemand C; Ertl IE; Lemberger U; Bruchbacher A; Brettner R; Korn S; Resch I; Comperat E; Shariat SF; Hassler MR
    Sci Rep; 2022 Jul; 12(1):12911. PubMed ID: 35902635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOBEC3B is expressed in human glioma, and influences cell proliferation and temozolomide resistance.
    Schmitt C; Lucius R; Synowitz M; Held-Feindt J; Hattermann K
    Oncol Rep; 2018 Nov; 40(5):2742-2749. PubMed ID: 30226610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer.
    Kim SH; Ahn S; Suh KJ; Kim YJ; Park SY; Kang E; Kim EK; Kim IA; Chae S; Choi M; Kim JH
    Breast Cancer Res Treat; 2020 Oct; 183(3):697-704. PubMed ID: 32715441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of APOBEC3A/3B germline deletion polymorphism in breast, cervical and oral cancers from South India and its impact on miRNA regulation.
    Revathidevi S; Manikandan M; Rao AK; Vinothkumar V; Arunkumar G; Rajkumar KS; Ramani R; Rajaraman R; Ajay C; Munirajan AK
    Tumour Biol; 2016 Sep; 37(9):11983-11990. PubMed ID: 27155849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOBEC3B deletion and risk of HIV-1 acquisition.
    An P; Johnson R; Phair J; Kirk GD; Yu XF; Donfield S; Buchbinder S; Goedert JJ; Winkler CA
    J Infect Dis; 2009 Oct; 200(7):1054-8. PubMed ID: 19698078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry.
    Xuan D; Li G; Cai Q; Deming-Halverson S; Shrubsole MJ; Shu XO; Kelley MC; Zheng W; Long J
    Carcinogenesis; 2013 Oct; 34(10):2240-3. PubMed ID: 23715497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between intact/deletion polymorphisms of the APOBEC3B gene and HIV-1 risk.
    Imahashi M; Izumi T; Watanabe D; Imamura J; Matsuoka K; Ode H; Masaoka T; Sato K; Kaneko N; Ichikawa S; Koyanagi Y; Takaori-Kondo A; Utsumi M; Yokomaku Y; Shirasaka T; Sugiura W; Iwatani Y; Naoe T
    PLoS One; 2014; 9(3):e92861. PubMed ID: 24667791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of HPV E6 and APOBEC3B in Upper Urinary Tract Urothelial Carcinoma.
    He L; Yang B; Jian D; Luo H; Wang D; Dai N
    Dis Markers; 2022; 2022():2147494. PubMed ID: 35903294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline APOBEC3B deletion influences clinicopathological parameters in luminal-A breast cancer: evidences from a southern Brazilian cohort.
    Vitiello GAF; de Sousa Pereira N; Amarante MK; Banin-Hirata BK; Campos CZ; de Oliveira KB; Losi-Guembarovski R; Watanabe MAE
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1523-1532. PubMed ID: 32285256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.